Immune regulatory activities of fowlicidin-1, a cathelicidin host defense peptide
• Fowlicidin-1(6-26) is chemotactic to neutrophils without enhancing their oxidative burst activity. • Fowl-1(6-26) activates macrophages by inducing chemokine/cytokine expression. • Fowl-1(6-26) activates macrophages also by enhancing the surface expression of MHC II and CD86. • Fowl-1(6-26) protec...
Ausführliche Beschreibung
Autor*in: |
Bommineni, Yugendar R. [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2014 |
---|
Schlagwörter: |
---|
Umfang: |
9 |
---|
Übergeordnetes Werk: |
Enthalten in: Letter regarding the article: Changes in BNP and cardiac troponin I after high-intensity interval and endurance exercise in heart failure patients and healthy controls - Gayda, Mathieu ELSEVIER, 2015, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:59 ; year:2014 ; number:1 ; pages:55-63 ; extent:9 |
Links: |
---|
DOI / URN: |
10.1016/j.molimm.2014.01.004 |
---|
Katalog-ID: |
ELV033685509 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV033685509 | ||
003 | DE-627 | ||
005 | 20230623231923.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180603s2014 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.molimm.2014.01.004 |2 doi | |
028 | 5 | 2 | |a GBVA2014003000028.pica |
035 | |a (DE-627)ELV033685509 | ||
035 | |a (ELSEVIER)S0161-5890(14)00013-3 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 570 |a 610 | |
082 | 0 | 4 | |a 570 |q DE-600 |
082 | 0 | 4 | |a 610 |q DE-600 |
082 | 0 | 4 | |a 610 |q VZ |
082 | 0 | 4 | |a 630 |a 640 |a 610 |q VZ |
100 | 1 | |a Bommineni, Yugendar R. |e verfasserin |4 aut | |
245 | 1 | 0 | |a Immune regulatory activities of fowlicidin-1, a cathelicidin host defense peptide |
264 | 1 | |c 2014 | |
300 | |a 9 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a • Fowlicidin-1(6-26) is chemotactic to neutrophils without enhancing their oxidative burst activity. • Fowl-1(6-26) activates macrophages by inducing chemokine/cytokine expression. • Fowl-1(6-26) activates macrophages also by enhancing the surface expression of MHC II and CD86. • Fowl-1(6-26) protects mice if given 1–4 days prior to MRSA infection. • Fowl-1(6-26) augments ovalbumin-specific adaptive immune response. | ||
650 | 7 | |a BHI |2 Elsevier | |
650 | 7 | |a i.p. |2 Elsevier | |
650 | 7 | |a HDP |2 Elsevier | |
650 | 7 | |a PMA |2 Elsevier | |
650 | 7 | |a IDR |2 Elsevier | |
650 | 7 | |a MRSA |2 Elsevier | |
650 | 7 | |a DCFDA |2 Elsevier | |
650 | 7 | |a OVA |2 Elsevier | |
650 | 7 | |a HBSS |2 Elsevier | |
650 | 7 | |a LPS |2 Elsevier | |
700 | 1 | |a Pham, Giang H. |4 oth | |
700 | 1 | |a Sunkara, Lakshmi T. |4 oth | |
700 | 1 | |a Achanta, Mallika |4 oth | |
700 | 1 | |a Zhang, Guolong |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier |a Gayda, Mathieu ELSEVIER |t Letter regarding the article: Changes in BNP and cardiac troponin I after high-intensity interval and endurance exercise in heart failure patients and healthy controls |d 2015 |g Amsterdam [u.a.] |w (DE-627)ELV012849286 |
773 | 1 | 8 | |g volume:59 |g year:2014 |g number:1 |g pages:55-63 |g extent:9 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.molimm.2014.01.004 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_227 | ||
912 | |a GBV_ILN_674 | ||
951 | |a AR | ||
952 | |d 59 |j 2014 |e 1 |h 55-63 |g 9 | ||
953 | |2 045F |a 570 |
author_variant |
y r b yr yrb |
---|---|
matchkey_str |
bommineniyugendarrphamgianghsunkaralaksh:2014----:mueeuaoyciiisfolcdnaahlcd |
hierarchy_sort_str |
2014 |
publishDate |
2014 |
allfields |
10.1016/j.molimm.2014.01.004 doi GBVA2014003000028.pica (DE-627)ELV033685509 (ELSEVIER)S0161-5890(14)00013-3 DE-627 ger DE-627 rakwb eng 570 610 570 DE-600 610 DE-600 610 VZ 630 640 610 VZ Bommineni, Yugendar R. verfasserin aut Immune regulatory activities of fowlicidin-1, a cathelicidin host defense peptide 2014 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Fowlicidin-1(6-26) is chemotactic to neutrophils without enhancing their oxidative burst activity. • Fowl-1(6-26) activates macrophages by inducing chemokine/cytokine expression. • Fowl-1(6-26) activates macrophages also by enhancing the surface expression of MHC II and CD86. • Fowl-1(6-26) protects mice if given 1–4 days prior to MRSA infection. • Fowl-1(6-26) augments ovalbumin-specific adaptive immune response. BHI Elsevier i.p. Elsevier HDP Elsevier PMA Elsevier IDR Elsevier MRSA Elsevier DCFDA Elsevier OVA Elsevier HBSS Elsevier LPS Elsevier Pham, Giang H. oth Sunkara, Lakshmi T. oth Achanta, Mallika oth Zhang, Guolong oth Enthalten in Elsevier Gayda, Mathieu ELSEVIER Letter regarding the article: Changes in BNP and cardiac troponin I after high-intensity interval and endurance exercise in heart failure patients and healthy controls 2015 Amsterdam [u.a.] (DE-627)ELV012849286 volume:59 year:2014 number:1 pages:55-63 extent:9 https://doi.org/10.1016/j.molimm.2014.01.004 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_40 GBV_ILN_227 GBV_ILN_674 AR 59 2014 1 55-63 9 045F 570 |
spelling |
10.1016/j.molimm.2014.01.004 doi GBVA2014003000028.pica (DE-627)ELV033685509 (ELSEVIER)S0161-5890(14)00013-3 DE-627 ger DE-627 rakwb eng 570 610 570 DE-600 610 DE-600 610 VZ 630 640 610 VZ Bommineni, Yugendar R. verfasserin aut Immune regulatory activities of fowlicidin-1, a cathelicidin host defense peptide 2014 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Fowlicidin-1(6-26) is chemotactic to neutrophils without enhancing their oxidative burst activity. • Fowl-1(6-26) activates macrophages by inducing chemokine/cytokine expression. • Fowl-1(6-26) activates macrophages also by enhancing the surface expression of MHC II and CD86. • Fowl-1(6-26) protects mice if given 1–4 days prior to MRSA infection. • Fowl-1(6-26) augments ovalbumin-specific adaptive immune response. BHI Elsevier i.p. Elsevier HDP Elsevier PMA Elsevier IDR Elsevier MRSA Elsevier DCFDA Elsevier OVA Elsevier HBSS Elsevier LPS Elsevier Pham, Giang H. oth Sunkara, Lakshmi T. oth Achanta, Mallika oth Zhang, Guolong oth Enthalten in Elsevier Gayda, Mathieu ELSEVIER Letter regarding the article: Changes in BNP and cardiac troponin I after high-intensity interval and endurance exercise in heart failure patients and healthy controls 2015 Amsterdam [u.a.] (DE-627)ELV012849286 volume:59 year:2014 number:1 pages:55-63 extent:9 https://doi.org/10.1016/j.molimm.2014.01.004 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_40 GBV_ILN_227 GBV_ILN_674 AR 59 2014 1 55-63 9 045F 570 |
allfields_unstemmed |
10.1016/j.molimm.2014.01.004 doi GBVA2014003000028.pica (DE-627)ELV033685509 (ELSEVIER)S0161-5890(14)00013-3 DE-627 ger DE-627 rakwb eng 570 610 570 DE-600 610 DE-600 610 VZ 630 640 610 VZ Bommineni, Yugendar R. verfasserin aut Immune regulatory activities of fowlicidin-1, a cathelicidin host defense peptide 2014 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Fowlicidin-1(6-26) is chemotactic to neutrophils without enhancing their oxidative burst activity. • Fowl-1(6-26) activates macrophages by inducing chemokine/cytokine expression. • Fowl-1(6-26) activates macrophages also by enhancing the surface expression of MHC II and CD86. • Fowl-1(6-26) protects mice if given 1–4 days prior to MRSA infection. • Fowl-1(6-26) augments ovalbumin-specific adaptive immune response. BHI Elsevier i.p. Elsevier HDP Elsevier PMA Elsevier IDR Elsevier MRSA Elsevier DCFDA Elsevier OVA Elsevier HBSS Elsevier LPS Elsevier Pham, Giang H. oth Sunkara, Lakshmi T. oth Achanta, Mallika oth Zhang, Guolong oth Enthalten in Elsevier Gayda, Mathieu ELSEVIER Letter regarding the article: Changes in BNP and cardiac troponin I after high-intensity interval and endurance exercise in heart failure patients and healthy controls 2015 Amsterdam [u.a.] (DE-627)ELV012849286 volume:59 year:2014 number:1 pages:55-63 extent:9 https://doi.org/10.1016/j.molimm.2014.01.004 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_40 GBV_ILN_227 GBV_ILN_674 AR 59 2014 1 55-63 9 045F 570 |
allfieldsGer |
10.1016/j.molimm.2014.01.004 doi GBVA2014003000028.pica (DE-627)ELV033685509 (ELSEVIER)S0161-5890(14)00013-3 DE-627 ger DE-627 rakwb eng 570 610 570 DE-600 610 DE-600 610 VZ 630 640 610 VZ Bommineni, Yugendar R. verfasserin aut Immune regulatory activities of fowlicidin-1, a cathelicidin host defense peptide 2014 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Fowlicidin-1(6-26) is chemotactic to neutrophils without enhancing their oxidative burst activity. • Fowl-1(6-26) activates macrophages by inducing chemokine/cytokine expression. • Fowl-1(6-26) activates macrophages also by enhancing the surface expression of MHC II and CD86. • Fowl-1(6-26) protects mice if given 1–4 days prior to MRSA infection. • Fowl-1(6-26) augments ovalbumin-specific adaptive immune response. BHI Elsevier i.p. Elsevier HDP Elsevier PMA Elsevier IDR Elsevier MRSA Elsevier DCFDA Elsevier OVA Elsevier HBSS Elsevier LPS Elsevier Pham, Giang H. oth Sunkara, Lakshmi T. oth Achanta, Mallika oth Zhang, Guolong oth Enthalten in Elsevier Gayda, Mathieu ELSEVIER Letter regarding the article: Changes in BNP and cardiac troponin I after high-intensity interval and endurance exercise in heart failure patients and healthy controls 2015 Amsterdam [u.a.] (DE-627)ELV012849286 volume:59 year:2014 number:1 pages:55-63 extent:9 https://doi.org/10.1016/j.molimm.2014.01.004 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_40 GBV_ILN_227 GBV_ILN_674 AR 59 2014 1 55-63 9 045F 570 |
allfieldsSound |
10.1016/j.molimm.2014.01.004 doi GBVA2014003000028.pica (DE-627)ELV033685509 (ELSEVIER)S0161-5890(14)00013-3 DE-627 ger DE-627 rakwb eng 570 610 570 DE-600 610 DE-600 610 VZ 630 640 610 VZ Bommineni, Yugendar R. verfasserin aut Immune regulatory activities of fowlicidin-1, a cathelicidin host defense peptide 2014 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Fowlicidin-1(6-26) is chemotactic to neutrophils without enhancing their oxidative burst activity. • Fowl-1(6-26) activates macrophages by inducing chemokine/cytokine expression. • Fowl-1(6-26) activates macrophages also by enhancing the surface expression of MHC II and CD86. • Fowl-1(6-26) protects mice if given 1–4 days prior to MRSA infection. • Fowl-1(6-26) augments ovalbumin-specific adaptive immune response. BHI Elsevier i.p. Elsevier HDP Elsevier PMA Elsevier IDR Elsevier MRSA Elsevier DCFDA Elsevier OVA Elsevier HBSS Elsevier LPS Elsevier Pham, Giang H. oth Sunkara, Lakshmi T. oth Achanta, Mallika oth Zhang, Guolong oth Enthalten in Elsevier Gayda, Mathieu ELSEVIER Letter regarding the article: Changes in BNP and cardiac troponin I after high-intensity interval and endurance exercise in heart failure patients and healthy controls 2015 Amsterdam [u.a.] (DE-627)ELV012849286 volume:59 year:2014 number:1 pages:55-63 extent:9 https://doi.org/10.1016/j.molimm.2014.01.004 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_40 GBV_ILN_227 GBV_ILN_674 AR 59 2014 1 55-63 9 045F 570 |
language |
English |
source |
Enthalten in Letter regarding the article: Changes in BNP and cardiac troponin I after high-intensity interval and endurance exercise in heart failure patients and healthy controls Amsterdam [u.a.] volume:59 year:2014 number:1 pages:55-63 extent:9 |
sourceStr |
Enthalten in Letter regarding the article: Changes in BNP and cardiac troponin I after high-intensity interval and endurance exercise in heart failure patients and healthy controls Amsterdam [u.a.] volume:59 year:2014 number:1 pages:55-63 extent:9 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
BHI i.p. HDP PMA IDR MRSA DCFDA OVA HBSS LPS |
dewey-raw |
570 |
isfreeaccess_bool |
false |
container_title |
Letter regarding the article: Changes in BNP and cardiac troponin I after high-intensity interval and endurance exercise in heart failure patients and healthy controls |
authorswithroles_txt_mv |
Bommineni, Yugendar R. @@aut@@ Pham, Giang H. @@oth@@ Sunkara, Lakshmi T. @@oth@@ Achanta, Mallika @@oth@@ Zhang, Guolong @@oth@@ |
publishDateDaySort_date |
2014-01-01T00:00:00Z |
hierarchy_top_id |
ELV012849286 |
dewey-sort |
3570 |
id |
ELV033685509 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV033685509</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623231923.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.molimm.2014.01.004</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014003000028.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV033685509</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0161-5890(14)00013-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">570</subfield><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">630</subfield><subfield code="a">640</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bommineni, Yugendar R.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Immune regulatory activities of fowlicidin-1, a cathelicidin host defense peptide</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Fowlicidin-1(6-26) is chemotactic to neutrophils without enhancing their oxidative burst activity. • Fowl-1(6-26) activates macrophages by inducing chemokine/cytokine expression. • Fowl-1(6-26) activates macrophages also by enhancing the surface expression of MHC II and CD86. • Fowl-1(6-26) protects mice if given 1–4 days prior to MRSA infection. • Fowl-1(6-26) augments ovalbumin-specific adaptive immune response.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">BHI</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">i.p.</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HDP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PMA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IDR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MRSA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DCFDA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">OVA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HBSS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LPS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pham, Giang H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sunkara, Lakshmi T.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Achanta, Mallika</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhang, Guolong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Gayda, Mathieu ELSEVIER</subfield><subfield code="t">Letter regarding the article: Changes in BNP and cardiac troponin I after high-intensity interval and endurance exercise in heart failure patients and healthy controls</subfield><subfield code="d">2015</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV012849286</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:59</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:55-63</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.molimm.2014.01.004</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_227</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_674</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">59</subfield><subfield code="j">2014</subfield><subfield code="e">1</subfield><subfield code="h">55-63</subfield><subfield code="g">9</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">570</subfield></datafield></record></collection>
|
author |
Bommineni, Yugendar R. |
spellingShingle |
Bommineni, Yugendar R. ddc 570 ddc 610 ddc 630 Elsevier BHI Elsevier i.p. Elsevier HDP Elsevier PMA Elsevier IDR Elsevier MRSA Elsevier DCFDA Elsevier OVA Elsevier HBSS Elsevier LPS Immune regulatory activities of fowlicidin-1, a cathelicidin host defense peptide |
authorStr |
Bommineni, Yugendar R. |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV012849286 |
format |
electronic Article |
dewey-ones |
570 - Life sciences; biology 610 - Medicine & health 630 - Agriculture & related technologies 640 - Home & family management |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
570 610 570 DE-600 610 DE-600 610 VZ 630 640 610 VZ Immune regulatory activities of fowlicidin-1, a cathelicidin host defense peptide BHI Elsevier i.p. Elsevier HDP Elsevier PMA Elsevier IDR Elsevier MRSA Elsevier DCFDA Elsevier OVA Elsevier HBSS Elsevier LPS Elsevier |
topic |
ddc 570 ddc 610 ddc 630 Elsevier BHI Elsevier i.p. Elsevier HDP Elsevier PMA Elsevier IDR Elsevier MRSA Elsevier DCFDA Elsevier OVA Elsevier HBSS Elsevier LPS |
topic_unstemmed |
ddc 570 ddc 610 ddc 630 Elsevier BHI Elsevier i.p. Elsevier HDP Elsevier PMA Elsevier IDR Elsevier MRSA Elsevier DCFDA Elsevier OVA Elsevier HBSS Elsevier LPS |
topic_browse |
ddc 570 ddc 610 ddc 630 Elsevier BHI Elsevier i.p. Elsevier HDP Elsevier PMA Elsevier IDR Elsevier MRSA Elsevier DCFDA Elsevier OVA Elsevier HBSS Elsevier LPS |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
g h p gh ghp l t s lt lts m a ma g z gz |
hierarchy_parent_title |
Letter regarding the article: Changes in BNP and cardiac troponin I after high-intensity interval and endurance exercise in heart failure patients and healthy controls |
hierarchy_parent_id |
ELV012849286 |
dewey-tens |
570 - Life sciences; biology 610 - Medicine & health 630 - Agriculture 640 - Home & family management |
hierarchy_top_title |
Letter regarding the article: Changes in BNP and cardiac troponin I after high-intensity interval and endurance exercise in heart failure patients and healthy controls |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV012849286 |
title |
Immune regulatory activities of fowlicidin-1, a cathelicidin host defense peptide |
ctrlnum |
(DE-627)ELV033685509 (ELSEVIER)S0161-5890(14)00013-3 |
title_full |
Immune regulatory activities of fowlicidin-1, a cathelicidin host defense peptide |
author_sort |
Bommineni, Yugendar R. |
journal |
Letter regarding the article: Changes in BNP and cardiac troponin I after high-intensity interval and endurance exercise in heart failure patients and healthy controls |
journalStr |
Letter regarding the article: Changes in BNP and cardiac troponin I after high-intensity interval and endurance exercise in heart failure patients and healthy controls |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
500 - Science 600 - Technology |
recordtype |
marc |
publishDateSort |
2014 |
contenttype_str_mv |
zzz |
container_start_page |
55 |
author_browse |
Bommineni, Yugendar R. |
container_volume |
59 |
physical |
9 |
class |
570 610 570 DE-600 610 DE-600 610 VZ 630 640 610 VZ |
format_se |
Elektronische Aufsätze |
author-letter |
Bommineni, Yugendar R. |
doi_str_mv |
10.1016/j.molimm.2014.01.004 |
dewey-full |
570 610 630 640 |
title_sort |
immune regulatory activities of fowlicidin-1, a cathelicidin host defense peptide |
title_auth |
Immune regulatory activities of fowlicidin-1, a cathelicidin host defense peptide |
abstract |
• Fowlicidin-1(6-26) is chemotactic to neutrophils without enhancing their oxidative burst activity. • Fowl-1(6-26) activates macrophages by inducing chemokine/cytokine expression. • Fowl-1(6-26) activates macrophages also by enhancing the surface expression of MHC II and CD86. • Fowl-1(6-26) protects mice if given 1–4 days prior to MRSA infection. • Fowl-1(6-26) augments ovalbumin-specific adaptive immune response. |
abstractGer |
• Fowlicidin-1(6-26) is chemotactic to neutrophils without enhancing their oxidative burst activity. • Fowl-1(6-26) activates macrophages by inducing chemokine/cytokine expression. • Fowl-1(6-26) activates macrophages also by enhancing the surface expression of MHC II and CD86. • Fowl-1(6-26) protects mice if given 1–4 days prior to MRSA infection. • Fowl-1(6-26) augments ovalbumin-specific adaptive immune response. |
abstract_unstemmed |
• Fowlicidin-1(6-26) is chemotactic to neutrophils without enhancing their oxidative burst activity. • Fowl-1(6-26) activates macrophages by inducing chemokine/cytokine expression. • Fowl-1(6-26) activates macrophages also by enhancing the surface expression of MHC II and CD86. • Fowl-1(6-26) protects mice if given 1–4 days prior to MRSA infection. • Fowl-1(6-26) augments ovalbumin-specific adaptive immune response. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_40 GBV_ILN_227 GBV_ILN_674 |
container_issue |
1 |
title_short |
Immune regulatory activities of fowlicidin-1, a cathelicidin host defense peptide |
url |
https://doi.org/10.1016/j.molimm.2014.01.004 |
remote_bool |
true |
author2 |
Pham, Giang H. Sunkara, Lakshmi T. Achanta, Mallika Zhang, Guolong |
author2Str |
Pham, Giang H. Sunkara, Lakshmi T. Achanta, Mallika Zhang, Guolong |
ppnlink |
ELV012849286 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth |
doi_str |
10.1016/j.molimm.2014.01.004 |
up_date |
2024-07-06T19:11:50.188Z |
_version_ |
1803858068308492288 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV033685509</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623231923.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.molimm.2014.01.004</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014003000028.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV033685509</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0161-5890(14)00013-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">570</subfield><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">630</subfield><subfield code="a">640</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bommineni, Yugendar R.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Immune regulatory activities of fowlicidin-1, a cathelicidin host defense peptide</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Fowlicidin-1(6-26) is chemotactic to neutrophils without enhancing their oxidative burst activity. • Fowl-1(6-26) activates macrophages by inducing chemokine/cytokine expression. • Fowl-1(6-26) activates macrophages also by enhancing the surface expression of MHC II and CD86. • Fowl-1(6-26) protects mice if given 1–4 days prior to MRSA infection. • Fowl-1(6-26) augments ovalbumin-specific adaptive immune response.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">BHI</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">i.p.</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HDP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PMA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IDR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MRSA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DCFDA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">OVA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HBSS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LPS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pham, Giang H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sunkara, Lakshmi T.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Achanta, Mallika</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhang, Guolong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Gayda, Mathieu ELSEVIER</subfield><subfield code="t">Letter regarding the article: Changes in BNP and cardiac troponin I after high-intensity interval and endurance exercise in heart failure patients and healthy controls</subfield><subfield code="d">2015</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV012849286</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:59</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:55-63</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.molimm.2014.01.004</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_227</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_674</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">59</subfield><subfield code="j">2014</subfield><subfield code="e">1</subfield><subfield code="h">55-63</subfield><subfield code="g">9</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">570</subfield></datafield></record></collection>
|
score |
7.3983126 |